If you want to own the entire investable US stock market in a single trade, VTI does exactly that. Vanguard Total Stock Market ETF (NYSEARCA:VTI) holds more than 3,500 stocks spanning every sector and market cap from mega-cap tech giants to small regional banks. It’s the closest thing to a set-it-and-forget-it equity position that exists. ... VTI May Hold 3,500 Stocks, But Three Companies Control ...
If you want to own the entire investable US stock market in a single trade, VTI does exactly that. Vanguard Total Stock Market ETF (NYSEARCA:VTI) holds more than 3,500 stocks spanning every sector and market cap from mega-cap tech giants to small regional banks. It’s the closest thing to a set-it-and-forget-it equity position that exists. ... VTI May Hold 3,500 Stocks, But Three Companies Control Nearly 20% of Your Money
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Tesla announced major leadership changes, including the exit of senior executive Raj Jegannathan. Joe Ward has been elevated to global head of sales as the company reshapes its management structure. The company is redirecting focus toward AI, robotics, and rob...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Tesla announced major leadership changes, including the exit of senior executive Raj Jegannathan. Joe Ward has been elevated to global head of sales as the company reshapes its management structure. The company is redirecting focus toward AI, robotics, and robotaxi development, supported by higher capital spending. These shifts come as demand for Tesla's core automotive business softens and the company rethinks its future growth drivers. Tesla, NasdaqGS:TSLA, is reworking its leadership team and business priorities at a time when its core vehicle segment faces weaker demand. The stock trades at $425.21, with a 1 year return of 29.4% and a 3 year return that is very large relative to that, while the 5 year return stands at 60.2%. Recent shorter term moves are mixed, with the share price up 0.8% over the past week and showing a 4.4% decline over 30 days. For investors, the key issue is how this shift toward AI, robotaxis, and humanoid robots might reshape Tesla's revenue mix over time. The combination of executive departures, Joe Ward's new role, and heavier spending on advanced technology indicates a company working to redefine its main engines of growth beyond traditional EV sales. Stay updated on the most important news stories for Tesla by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Tesla. NasdaqGS:TSLA 1-Year Stock Price Chart Does the team leading Tesla have what it takes? See our full breakdown of the management team's track record and compensation. For you as a shareholder, these leadership moves sit at the junction of weaker core-auto results and a heavy pivot into AI, robotics and robotaxis. The exit of long-tenured executives like Raj Jegannathan, who was involved in both sales and AI infrastructure, raises questions about execution stability at the same...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Tesla announced major leadership changes, including the exit of senior executive Raj Jegannathan. Joe Ward has been elevated to global head of sales as the company reshapes its management structure. The company is redirecting focus toward AI, robotics, and rob...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Tesla announced major leadership changes, including the exit of senior executive Raj Jegannathan. Joe Ward has been elevated to global head of sales as the company reshapes its management structure. The company is redirecting focus toward AI, robotics, and robotaxi development, supported by higher capital spending. These shifts come as demand for Tesla's core automotive business softens and the company rethinks its future growth drivers. Tesla, NasdaqGS:TSLA, is reworking its leadership team and business priorities at a time when its core vehicle segment faces weaker demand. The stock trades at $425.21, with a 1 year return of 29.4% and a 3 year return that is very large relative to that, while the 5 year return stands at 60.2%. Recent shorter term moves are mixed, with the share price up 0.8% over the past week and showing a 4.4% decline over 30 days. For investors, the key issue is how this shift toward AI, robotaxis, and humanoid robots might reshape Tesla's revenue mix over time. The combination of executive departures, Joe Ward's new role, and heavier spending on advanced technology indicates a company working to redefine its main engines of growth beyond traditional EV sales. Stay updated on the most important news stories for Tesla by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Tesla. NasdaqGS:TSLA 1-Year Stock Price Chart Does the team leading Tesla have what it takes? See our full breakdown of the management team's track record and compensation. For you as a shareholder, these leadership moves sit at the junction of weaker core-auto results and a heavy pivot into AI, robotics and robotaxis. The exit of long-tenured executives like Raj Jegannathan, who was involved in both sales and AI infrastructure, raises questions about execution stability at the same...
Avantor press release ( AVTR ): Q4 Non-GAAP EPS of $0.22 in-line. Revenue of $1.66B (-1.8% Y/Y) beats by $20M . More on Avantor Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on Avantor Historical earnings data for Avantor Financial info...
Avantor press release ( AVTR ): Q4 Non-GAAP EPS of $0.22 in-line. Revenue of $1.66B (-1.8% Y/Y) beats by $20M . More on Avantor Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on Avantor Historical earnings data for Avantor Financial information for Avantor
Solstice Advanced Materials, Inc. press release ( SOLS ): Q4 GAAP EPS of $0.26. Revenue of $987M (+8.1% Y/Y). Company provides Full-Year 2026 Guidance; expects Net Sales of $3.9-$4.1 billion, Adjusted EBITDA of $975-$1,025 million, Adjusted Diluted Earnings per Share of $2.45-$2.75 (vs. consensus of $2.88) More on Solstice Advanced Materials, Inc. Solstice: Questions On The Latest Honeywell Spin-O...
Solstice Advanced Materials, Inc. press release ( SOLS ): Q4 GAAP EPS of $0.26. Revenue of $987M (+8.1% Y/Y). Company provides Full-Year 2026 Guidance; expects Net Sales of $3.9-$4.1 billion, Adjusted EBITDA of $975-$1,025 million, Adjusted Diluted Earnings per Share of $2.45-$2.75 (vs. consensus of $2.88) More on Solstice Advanced Materials, Inc. Solstice: Questions On The Latest Honeywell Spin-Off Solstice Advanced Materials, Inc. (SOLS) Presents at Goldman Sachs Industrials and Materials Conference 2025 Transcript ClearBridge Small Cap Strategy adds Upwork, exits Alexander & Baldwin in Q4 Seeking Alpha’s Quant Rating on Solstice Advanced Materials, Inc. Historical earnings data for Solstice Advanced Materials, Inc.
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Astera Labs stock snapshot after recent performance Astera Labs (ALAB) has drawn fresh attention after recent share price moves, including a 2.6% decline over the past day following gains of 26.4% over the past week. See our latest analysis for Astera Labs. The recent 7 day share pric...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Astera Labs stock snapshot after recent performance Astera Labs (ALAB) has drawn fresh attention after recent share price moves, including a 2.6% decline over the past day following gains of 26.4% over the past week. See our latest analysis for Astera Labs. The recent 7 day share price return of 26.4% stands out against a year to date share price return of 1.84% and a 1 year total shareholder return of 108.98%, suggesting recent momentum has picked up from a much stronger longer term base. If this kind of AI infrastructure move has your attention, it could be a good time to see what else is shaping up in our list of 33 AI infrastructure stocks. With Astera Labs posting a 1 year total return above 100% and trading at a discount of about 11% to the average analyst price target, investors may ask whether there is still a buying opportunity or if the market is already pricing in future growth. Most Popular Narrative: 8.2% Undervalued Astera Labs' most followed narrative sets a fair value of $199.15 per share, above the last close at $182.86. This frames the current valuation debate. Expansion across multiple high growth connectivity standards (PCIe, Ethernet, CXL, and UALink), alongside deepening partnerships with leading industry players (NVIDIA, AMD, Microsoft, SAP, Alchip), positions Astera Labs to leverage the ongoing digital transformation and migration to advanced data center architectures. This reduces customer concentration risk while supporting higher gross margins from increased product mix and attach rates. Read the complete narrative. Curious what earnings power that kind of product mix implies, and what sort of margin profile has been baked into that fair value, the full narrative breaks down those assumptions in plain numbers. Result: Fair Value of $199.15 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the fore...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Astera Labs stock snapshot after recent performance Astera Labs (ALAB) has drawn fresh attention after recent share price moves, including a 2.6% decline over the past day following gains of 26.4% over the past week. See our latest analysis for Astera Labs. The recent 7 day share pric...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Astera Labs stock snapshot after recent performance Astera Labs (ALAB) has drawn fresh attention after recent share price moves, including a 2.6% decline over the past day following gains of 26.4% over the past week. See our latest analysis for Astera Labs. The recent 7 day share price return of 26.4% stands out against a year to date share price return of 1.84% and a 1 year total shareholder return of 108.98%, suggesting recent momentum has picked up from a much stronger longer term base. If this kind of AI infrastructure move has your attention, it could be a good time to see what else is shaping up in our list of 33 AI infrastructure stocks. With Astera Labs posting a 1 year total return above 100% and trading at a discount of about 11% to the average analyst price target, investors may ask whether there is still a buying opportunity or if the market is already pricing in future growth. Most Popular Narrative: 8.2% Undervalued Astera Labs' most followed narrative sets a fair value of $199.15 per share, above the last close at $182.86. This frames the current valuation debate. Expansion across multiple high growth connectivity standards (PCIe, Ethernet, CXL, and UALink), alongside deepening partnerships with leading industry players (NVIDIA, AMD, Microsoft, SAP, Alchip), positions Astera Labs to leverage the ongoing digital transformation and migration to advanced data center architectures. This reduces customer concentration risk while supporting higher gross margins from increased product mix and attach rates. Read the complete narrative. Curious what earnings power that kind of product mix implies, and what sort of margin profile has been baked into that fair value, the full narrative breaks down those assumptions in plain numbers. Result: Fair Value of $199.15 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the fore...
(RTTNews) - Below are the earnings highlights for Hilton Worldwide Holdings, Inc. (HLT): Earnings: $297 million in Q4 vs. $505 million in the same period last year. EPS: $1.27 in Q4 vs. $2.06 in the same period last year. Excluding items, Hilton Worldwide Holdings, Inc. reported adjusted earnings of $190 million or $2.08 per share for the period. Revenue: $3.087 billion in Q4 vs. $2.783 billion in...
(RTTNews) - Below are the earnings highlights for Hilton Worldwide Holdings, Inc. (HLT): Earnings: $297 million in Q4 vs. $505 million in the same period last year. EPS: $1.27 in Q4 vs. $2.06 in the same period last year. Excluding items, Hilton Worldwide Holdings, Inc. reported adjusted earnings of $190 million or $2.08 per share for the period. Revenue: $3.087 billion in Q4 vs. $2.783 billion in the same period last year. -Guidance: Next quarter EPS guidance: $ 1.91 To $ 1.97 The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Generac press release ( GNRC ): Q4 Non-GAAP EPS of $1.61 misses by $0.16 . Revenue of $1.09B (-11.4% Y/Y) misses by $70M . The Company is initiating its full-year 2026 net sales growth guidance to be in the mid-teens percent range as compared to the prior year, which includes a 1% favorable impact from the net effect of foreign currency and completed acquisitions and divestitures. Adjusted EBITDA ...
Generac press release ( GNRC ): Q4 Non-GAAP EPS of $1.61 misses by $0.16 . Revenue of $1.09B (-11.4% Y/Y) misses by $70M . The Company is initiating its full-year 2026 net sales growth guidance to be in the mid-teens percent range as compared to the prior year, which includes a 1% favorable impact from the net effect of foreign currency and completed acquisitions and divestitures. Adjusted EBITDA margin, before deducting for non-controlling interests, is expected to be approximately 18.0 to 19.0% More on Generac From Storms To Servers: Why Generac Holdings' Moment May Be Here Generac: Lagging Among Industrials, Banking On AI Demand Generac Q4 2025 Earnings Preview Generac upgraded at Baird, seeing 'unique opportunity ahead' in large diesel gensets Seeking Alpha’s Quant Rating on Generac
Amazon (AMZN) Shares Attempt to Stabilise After Disappointing Results Amazon (AMZN) shares have come under significant pressure following the company’s weak earnings report on 5 February, as shown by the chart: → Revenue: $213.4 bn (expected: $211.4 bn) → EPS: $1.95 (expected: $1.97) The report was weighed down by Amazon’s announcement that it plans to spend $200 bn on capital projects in 2026, la...
Amazon (AMZN) Shares Attempt to Stabilise After Disappointing Results Amazon (AMZN) shares have come under significant pressure following the company’s weak earnings report on 5 February, as shown by the chart: → Revenue: $213.4 bn (expected: $211.4 bn) → EPS: $1.95 (expected: $1.97) The report was weighed down by Amazon’s announcement that it plans to spend $200 bn on capital projects in 2026, largely targeting AI, data centres, and chip production. This represents a roughly 60% increase from last year and far exceeds analysts’ projections of around $146 bn. Investors may be concerned that the escalating AI competition with Microsoft and Google could prove costly, with monetisation likely taking years and success remaining uncertain. Following the earnings release, two broad bearish gaps formed below the $232 and $220 levels, signalling heightened downside pressure. Amazon (AMZN) Technical Outlook Since June last year, a thick trendline had acted as a reliable support, considered a favourable entry point for AMZN shares. However, this line has now been decisively broken. Constructing a channel using this trendline as the median and the previous high as the upper boundary, the line separating the channel’s lower two quarters (QL) currently functions as short-term support. The gap zones are likely to act as resistance, and negative market sentiment is expected to continue applying pressure on the stock. If bearish momentum persists, the QL line and the key psychological $200 level could be breached, raising concerns further. Under this scenario, the share price could drop towards the lower boundary of the channel, around $188. FXOpen offers spreads from 0.0 pips and commissions from $1.50 per lot (additional fees may apply). Enjoy trading on MT4, MT5, TickTrader or TradingView trading platforms! The FXOpen App is a dedicated mobile application designed to give traders full control of their accounts anytime, anywhere. This article represents the opinion of the Compani...
Humana press release ( HUM ): Q4 Non-GAAP EPS of -$3.96 beats by $0.03 . Adj. Revenue of $32.64B (+11.7% Y/Y) beats by $630M . 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'a...
Humana press release ( HUM ): Q4 Non-GAAP EPS of -$3.96 beats by $0.03 . Adj. Revenue of $32.64B (+11.7% Y/Y) beats by $630M . 4Q25 Insurance segment GAAP benefit ratio of 93.1 percent; FY 2025 Insurance segment GAAP benefit ratio of 90.4 percent, slightly better than guidance of 'the top end of the range of 90.1 percent to 90.5 percent' Introduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of mitigation Anticipates FY 2026 individual Medicare Advantage membership growth of 'approximately 25 percent' over 2025; driven by new sales and improved retention from the company's customer-led benefit strategy and changes to its customer service approach Continued growth in the CenterWell and Medicaid platforms Growth of 100,600 patients, or over 25 percent, in CenterWell Senior Primary Care during 2025, including approximately 32,000 patients associated with the acquisition of The Villages Health Expanded Medicaid footprint, which now spans 13 states, including Georgia and Texas which are expected to launch in 2027 FY26 EPS consensus of $12.00 Diluted earnings per share (a) FY 2026Guidance FY 2025 GAAP at least $8.89 $9.84 Amortization associated with identifiable intangibles 0.15 0.42 Put/call valuation adjustments associated with the company's non-consolidating minority interest investments (b) — 4.25 Value creation initiatives (b) — 3.72 Impact of exit of employer group commercial medical products business (b) — (0.52 ) Settlement of certain litigation expenses (b) — 0.13 Loss on sale of business (b) — 0.55 Impairment charges (b) — 2.09 Cumulative net tax impact (0.04 ) (3.34 ) Adjusted (non-GAAP) – FY 2026 projected (b); FY 2025 reported at least $9.00 $17.14 Click to enlarge Shares -1.8% PM. More on Humana Humana: Market Is Right To Be Skeptical UnitedHealth, Humana: CMS' Rate Decision Has Crushed Stock, & There's No Quick Fi...
Key Points Higher-margin international equipment demand is offsetting domestic shale weakness. Strong cost controls and lower capital expenditures should continue to improve cash flow. The company returned $1.6 billion to shareholders in 2025 through buybacks and dividends. 10 stocks we like better than Halliburton › Shares of Halliburton (NYSE: HAL) have been on a tear, climbing 55% since the oil...
Key Points Higher-margin international equipment demand is offsetting domestic shale weakness. Strong cost controls and lower capital expenditures should continue to improve cash flow. The company returned $1.6 billion to shareholders in 2025 through buybacks and dividends. 10 stocks we like better than Halliburton › Shares of Halliburton (NYSE: HAL) have been on a tear, climbing 55% since the oilfield services company beat third-quarter earnings estimates in October. After trading near multiyear lows throughout the summer, the stock has erased all of last year's losses as the market recognizes that management's cost initiatives are taking hold and global demand is improving. Fourth-quarter revenue was little changed sequentially and up only 1% year over year, but profitability showed signs of life despite a declining domestic rig count. In Q4, adjusted operating margins reached 15% after falling from 17% in 2024 to 13% in Q2 2025. In addition to the recent headcount adjustments, revenue from higher-margin international contracts rose, lifting operating income. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » In Q3, management announced a reduction in overhead and labor expected to save the company roughly $400 million annually. Pair this with a planned pullback in this year's capital expenditures (capex) budget, and the disciplined spending should stabilize profitability and cash flow while Halliburton navigates headwinds on its home turf. International rebound outweighs shale drag The domestic business continues to face challenges as exploration & production (E&P) operators prioritize capital returns over production growth. In Q4 2025, North American sales dropped 7% sequentially to $2.2 billion, reflecting lower shale activity in the U.S. Currently, the region accounts for roughly 40% of Halliburton's total revenue, down from previous cycles. D...